Search

Search Results
Results 2371 - 2380 of 2423 for Arrhythmia
  • Ribomustin
    Drug - 17 Oct 2022
    Consumer Medicine Information (CMI) about Ribomustin (Bendamustine Hydrochloride) intended for persons living in Australia.
  • Uptravi
    Drug - 21 Sep 2022
    Consumer Medicine Information (CMI) about Uptravi (Selexipag 200, 400, 600, 800, 1000, 1200, 1400, 1600 micrograms film coated tablets) intended for persons living in Australia.
  • Kanjinti
    Drug - 11 Feb 2022
    Consumer Medicine Information (CMI) about Kanjinti (trastuzumab) intended for persons living in Australia.
  • Daunorubicin
    Drug - 23 Dec 2021
    Consumer Medicine Information (CMI) about Daunorubicin (Daunorubicin hydrochloride) intended for persons living in Australia.
  • Lecteva
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Lecteva (levodopa/carbidopa/entacapone) intended for persons living in Australia.
  • Adefin
    Drug - 14 Jan 2020
    Consumer Medicine Information (CMI) about Adefin (nifedipine tablets) intended for persons living in Australia.
  • Adefin XL
    Drug - 14 Jan 2020
    Consumer Medicine Information (CMI) about Adefin XL (nifedipine) intended for persons living in Australia.
  • Pfizer Daunorubicin
    Drug - 20 Nov 2024
    Consumer Medicine Information (CMI) about Pfizer Daunorubicin intended for persons living in Australia.
  • Durogesic
    Drug - 17 Nov 2024
    Consumer Medicine Information (CMI) about Durogesic intended for persons living in Australia.
  • Haldol
    Drug - 17 Nov 2024
    Consumer Medicine Information (CMI) about Haldol intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback